<unk>  (G/P), sold under the brand names Mavyret and Maviret, is a fixed-dose combination medication used to treat hepatitis C. It contains<unk>  and<unk> . It works against all six types of hepatitis C. At twelve weeks following treatment between 81% and 100% of people have no evidence of hepatitis C. It is taken once a day by mouth with food. The most common side effects are headache, diarrhea, and tiredness. In those with a history of hepatitis B reactivation may occur. It is not recommended in people with moderate to severe liver disease.<unk>  works by blocking the protein NS3/4A protease, while<unk>  works by blocking NS5A. The combination was approved for medical use in the United States and Europe in 2017. It is on the World Health Organization's List of Essential Medicines.
Glecaprevir/pibrentasvir
Ombitasvir/paritaprevir/ritonavir
Abacavir/lamivudine
Atazanavir/cobicistat
Atazanavir/ritonavir
Darunavir/cobicistat
Elbasvir/grazoprevir
Sofosbuvir/velpatasvir